HopeStage
Back to all studies
RecruitingNCT05630781

Suvorexant and brain responses to substance-use cues

About this title

Orexin s Role in the Neurobiology of Substance Use Disorder

Read the official source — NCT05630781
Medication studyAges 18–60United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 60 years.

Listed locations
BaltimoreSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 15, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
140
Sponsor
National Institute on Drug Abuse (NIDA)
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT05630781
Official title
Show the full official title

Orexin's Role in The Neurobiology of Substance Use Disorder

Recruitment & locations

Currently recruiting

Baltimore

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute on Drug Abuse (NIDA), a research institute.

Does this study involve medication?

Yes. The study involves medication, including Belsomra, Placebo and Methylphenidate.

Who can participate?

Listed age limits: 18 years to 60 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies